Stimulants: Therapeutic Actions in ADHD
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Stimulants such as methylphenidate and amphetamine are currently the most common treatment for attention deficit hyperactivity disorder (ADHD). For years, it was assumed that stimulants had paradoxical calming effects in ADHD patients, whereas stimulating 'normal' individuals and producing locomotor activation in rats. It is now known that low doses of stimulants focus attention and improve executive function in both normal and ADHD subjects. Furthermore, the seminal work of Kuczenski and Segal showed that low, oral doses of methylphenidate reduce locomotor activity in rats as well. Berridge et al have now shown that these low doses produce marked increases in norepinephrine and dopamine release in the prefrontal cortex, whereas having only subtle effects on subcortical catecholamine release. ihe prefrontal cortex regulates behavior and attention using representational knowledge, and imaging and neuropsychological studies have shown that the prefrontal cortex is weaker in subjects with ADHD. This cortical area is very sensitive to levels of catecholamines: moderate levels engage postsynaptic alpha2A-adrenoceptors and D1 receptors and improve prefrontal regulation of behavior and attention, while high levels impair prefrontal function via alpha1-adrenoceptors and excessive D1 receptor stimulation. Administering low doses of methylphenidate to rats improves the working memory and attentional functions of the prefrontal cortex, while high doses impair working memory and produce…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Stimulants, such as those used to treat attention-deficit/hyperactivity disorder (ADHD), preferentially modulate central DA and, to a lesser extent, NE systems (Arnsten, 2006).”
From Lisdexamfetamine Dimesylate Augmentation in Adults With Persistent Executive Dysfunction After Partial or Full Remission of Major Depressive Disorder (2014) · cites this paper as Arnsten, 2006
In the citing paper
“For college students with ADHD who have difficulties with attention and neuropsychological deficits (NPDs; e.g., difficulties with EFs) due to dopamine deficits, stimulant medication helps these students by increasing dopamine to typical levels (Arnsten, 2006; Dela Peña et al., 2015; Willcutt, 2015).”
From Effects of stimulant medication on neuropsychological functioning in college students without ADHD. (2026) · cites this paper as Arnsten, 2006
In the citing paper
“stimulants like methylphenidate and amphetamine, which increase prefrontal catecholamines, have commonly been used to treat cognitive dysfunction such as working memory impairments in patients with ADHD (Arnsten 2006, Pietrzak et al 2006).”
From Prefrontal cortex executive processes affected by stress in health and disease (2018) · cites this paper as Arnsten 2006, Pietrzak et al 2006
Citations
Cites
Inhibition and the right inferior frontal cortex
Aron, A. R., Robbins, T. W., & Poldrack, R. A. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.02.010 · Cited by 3,197 · cited 2×
“The right inferior prefrontal cortex is particularly important for behavioral inhibition (reviewed in Aron et al, 2004).”
BackgroundCellular basis of working memory
Goldman-Rakic, P. S. (1995) · Neuron · doi:10.1016/0896-6273(95)90304-6 · Cited by 2,663 · cited 2×
“Moderate levels of D1/D5 receptor stimulation suppress delay-related firing for nonpreferred spatial directions (ie ‘noise’), and thus enhance spatial tuning (Williams and Goldman-Rakic, 1995; Vijayraghavan et al, 2006).”
BackgroundMolecular genetics of attention-deficit/hyperactivity disorder
Faraone, S. V., Perlis, R. H., Doyle, A. E., Smoller, J. W., Goralnick, J. J., Holmgren, M. A., & Sklar, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.024 · Cited by 2,357 · cited 2×
“ADHD is often an inherited disorder, and many of the genes associated with ADHD code for molecules involved with catecholamine transmission (reviewed in Faraone et al, 2005).”
BackgroundVan Tol, H. H. M., Bunzow, J. R., Guan, H.-C., Sunahara, R. K., Seeman, P., Niznik, H. B., & Civelli, O. (1991) · Nature · doi:10.1038/350610a0 · Cited by 2,014 · cited 1×
“It should be noted that the D4 receptor has very high affinity for norepinephrine (Van Tol et al, 1991) and should really be considered a catecholamine receptor.”
BackgroundPrinciples of Frontal Lobe Function
(2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134971.001.0001 · Cited by 1,665
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646 · cited 2×
“Many of these studies have also found reduced volume of cerebellum, caudate, and corpus callosum (Seidman et al, 2005; Castellanos et al, 2002).”
BackgroundModulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593 · cited 1×
“Moderate levels of D1/D5 receptor stimulation suppress delay-related firing for nonpreferred spatial directions (ie ‘noise’), and thus enhance spatial tuning (Williams and Goldman-Rakic, 1995; Vijayraghavan et al, 2006).”
BackgroundImpairment of social and moral behavior related to early damage in human prefrontal cortex
Anderson, S. W., Bechara, A., Damasio, H., Tranel, D., & Damasio, A. R. (1999) · Nature Neuroscience · doi:10.1038/14833 · Cited by 1,539 · cited 1×
“Lesions in the ventromedial prefrontal cortex can impair regulation of emotion, and result in inappropriate social behaviors such as aggression (Anderson et al, 1999).”
BackgroundDissociation in prefrontal cortex of affective and attentional shifts
Dias, R., Robbins, T. W., & Roberts, A. C. (1996) · Nature · doi:10.1038/380069a0 · Cited by 1,527 · cited 1×
“Similar results have been seen in animals, where prefrontal cortex lesions impair attentional regulation in monkeys (Malmo, 1942; Bartus and Levere, 1977; Dias et al, 1996), and rats (Muir et al, 1996).”
ResultADHD and The Nature of Self-Control
Barkley, R. A., & Wasserstein, J. (2000) · Journal of Cognitive Psychotherapy · doi:10.1891/0889-8391.14.1.111 · Cited by 1,513
Cited by
Items 201–300 of 538
Salek, R. L., Claussen, C. M., Perez, A. M., & Dafny, N. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.01.009 · Cited by 33
“Introduction The psychostimulant (methylphenidate MPD) has become the most prescribed drug or attention deficit hyperactivity disorder (ADHD) (Eichlseder, 1985; Solanto, 1998; Swanson et al., 1999; Challman and Lipsky, 2000; Accardo and Blondis, 2001; Arnsten, 2006).”
BackgroundMethodFries, G. R., Valvassori, S. S., Bock, H., Stertz, L., Magalhães, P. V. D. S., Mariot, E., Varela, R. B., Kauer‐Sant’Anna, M., Quevedo, J., Kapczinski, F. P., et al. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.05.006 · Cited by 32
Albayrak, Ö., Albrecht, B., Scherag, S., Barth, N., Hinney, A., & Hebebrand, J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.12.023 · Cited by 32
Parent and Family Processes Related to ADHD Management in Ethnically Diverse Youth
Paidipati, C. P., Brawner, B. M., Eiraldi, R. B., & Deatrick, J. A. (2017) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390316687023 · Cited by 32
“These findings may be due to system-level challenges and obstacles for accessing and maintaining care (Bailey & Owens, 2005; Santiago et al., 2011).”
Psychostimulants As Cognitive Enhancers in Adolescents: More Risk than Reward?
Urban, K. R., & Gao, W. (2017) · Frontiers in Public Health · doi:10.3389/fpubh.2017.00260 · Cited by 33
Clements, K. M., Devonshire, I. M., Reynolds, J. N. J., & Overton, P. G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.054 · Cited by 30
Critical analysis of the concept of adult attention-deficit hyperactivity disorder
Moncrieff, J., & Timimi, S. B. (2011) · The Psychiatrist · doi:10.1192/pb.bp.110.033423 · Cited by 30
Son, D. V., Schalbroeck, R., Angelidis, A., van der Wee, N. J. A., van der Does, W. A. J., & Putman, P. (2018) · Biological Psychology · doi:10.1016/j.biopsycho.2018.05.006 · Cited by 33
“…et al., 2018; van Son et al., 2018) and assuming that such basal prefrontal attentional control is regulated by prefrontal catecholamine levels (Arnsten, 2006; Hermans et al., 2014), the established model of inverted U-shape relations between prefrontal catecholamine activity and cognitive…”
BackgroundInfluentialMeneses, A., Ponce-López, T., Tellez, R., González, R., Castillo, C., & Gasbarri, A. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.08.035 · Cited by 29
Humpston, C. S., Wood, C. M., & Robinson, E. S. J. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112466182 · Cited by 29
“Current treatments for ADHD are drugs such as methylphenidate and atomoxetine, which primarily target the catecholamine transmitters, noradrenaline and dopamine (Arnsten, 2006; Braquehais et al., 2010; Wilens, 2006).”
Background‘Waiting impulsivity’ in isolation-reared and socially-reared rats: effects of amphetamine
Liu, Y., Wilkinson, L. S., & Robbins, T. W. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4579-8 · Cited by 28
“In addition to hyperactivity, ADHD also entails symptoms of impulsivity (i.e. either ‘ impulsive action ’ or increased ‘ impulsive choice ’ for smaller sooner rewards compared with delayed, larger ones, i.e. during the temporal discounting of reward task, TDRT), and inattention (Sjöwall et al.…”
BackgroundInfluentialManeeton, B., Maneeton, N., Intaprasert, S., & Wootiluk, P. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62714 · Cited by 27
Lawn, T., Giacomel, A., Martins, D., Veronese, M., Howard, M. A., Turkheimer, F., & Dipasquale, O. (2024) · Communications Biology · doi:10.1038/s42003-024-06391-3 · Cited by 28
“The catecholamines are long implicated in the pathophysiology and treatment of ADHD 109,110 , adding credence to these similarity analyses which may offer an alternative lens through which to view the pattern of deviations across subjects.”
Grazioli, S., Mauri, M., Crippa, A., Maggioni, E., Molteni, M., Brambilla, P., & Nobile, M. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.10.100 · Cited by 27
Dopamine in socioecological and evolutionary perspectives: implications for psychiatric disorders
Yamaguchi, Y., Lee, Y., & Goto, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00219 · Cited by 29
“An association of an increased risk of ADHD has also been suggested with 148 bpmicrosatellite located 18.5 kb to the 5′ end of DA D5 receptor gene (DRD5) (Li et al., 2006).”
BackgroundInfluentialRibasés, M., Sánchez‐Mora, C., Ramos‐Quiroga, J. A., Bosch, R., Gómez-Barros, N., Nogueira, M., Corrales, M., Palomar, G., Jacob, C., Groß‐Lesch, S., et al. (2012) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328353957e · Cited by 26
“This hypothesis is also supported by additional data that include the control that FOXP2 exerts on the activity of the corticobasal ganglia circuits known to contribute to ADHD (Bush et al., 2005; Seidman et al., 2005; Arnsten, 2006; Enard et al., 2009; Lieberman, 2009), its association with other psychiatric disorder…”
BackgroundResultFrom neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
“As discussed above, an optimal stimulation of these receptors enhances PFC function, by respectively reducing ‘noise ’ and enhancing ‘signal ’ within glutamatergic circuits (Arnsten, 2006, Arns-ten, 2009, Arnsten and Rubia, 2012).”
BackgroundGahr, M., & Plener, P. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00065-2 · Cited by 26
Stimulant medications affect arousal and reward, not attention networks
Kay, B. P., Wheelock, M. D., Siegel, J. S., Raut, R. V., Chauvin, R. J., Metoki, A., Rajesh, A., Eck, A., Pollaro, J., Wang, A., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.039 · Cited by 27
“8,9,20,162,163 124 Remarkably, we found that taking a stimulant before scanning made the brain connectivity of children with less sleep indistinguishable from that of well-rested children.”
Zhang, X., Yan, H., Yu, H., Zhao, X., Shah, S., Dong, Z., Yang, G., Zhang, X., Muse, T., Li, J., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01650-x · Cited by 26
Park, S., Kim, J.-W., Yang, Y.-H., Hong, S., Park, M.-H., Kim, B., Shin, M., Yoo, H., & Cho, S.-C. (2012) · Behavioral and Brain Functions · doi:10.1186/1744-9081-8-22 · Cited by 26
Kim, B.-N., Kim, J.-W., Cummins, T. D. R., Bellgrove, M. A., Hawi, Z., Hong, S.-B., Yang, Y.-H., Kim, H.-J., Shin, M., Cho, S.-C., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31828f9fc3 · Cited by 26
Mapping the central effects of methylphenidate in the rat using pharmacological MRI BOLD contrast
Easton, N., Marshall, F. H., Marsden, C. A., & Fone, K. C. F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.018 · Cited by 25
“For instance, the increase in neuronal excitability recorded in PFC slices depends on catecholamine release and the activation of a2 adrenoreceptors therein (Andrews and Lavin, 2006) and low doses of MPH enhance working memory in rodents by a2 adrenoreceptor activation (Arnsten, 2006).”
BackgroundHiraide, S., Ueno, K.-I., Yamaguchi, T., Matsumoto, M., Yanagawa, Y., Yoshioka, M., & Togashi, H. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.01.009 · Cited by 24
Lisdexamfetamine: A prodrug for the treatment of attention-deficit/hyperactivity disorder
Popovic, B., Bhattacharya, P., & Sivaswamy, L. (2009) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp080353 · Cited by 24
Caballero-Puntiverio, M., Lerdrup, L., Arvastson, L., Aznar, S., & Andreasen, J. T. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109823 · Cited by 23
Stevenson, M. P., McEwan, J., Bentsen, P., Schilhab, T. S. S., Glue, P., Trani, P., Wheeler, B. J., & Healey, D. M. (2021) · Journal of Environmental Psychology · doi:10.1016/j.jenvp.2021.101679 · Cited by 24
Seo, E. H., Yang, H.-J., Kim, S.-G., Park, S., Lee, S., & Yoon, H. (2021) · Psychiatry Investigation · doi:10.30773/pi.2021.0207 · Cited by 24
The Prefrontal Cortex and Executive Brain Functions
Miller, E. K., & Wallis, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385870-2.00050-0 · Cited by 23
Britton, G. B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000472 · Cited by 23
“The prefrontal cortex (PFC) circuitry directs goal-driven behaviours, regulates attentional processes, and inhibits inappropriate responses, functions that are impaired in ADHD and are improved with MPH (Arnsten, 2006).”
BackgroundResultInfluentialMizuno, Y., Cai, W., Supekar, K., Makita, K., Takiguchi, S., Silk, T. J., Tomoda, A., & Menon, V. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.10.001 · Cited by 22
“Altered dopamine signaling has been hypothesized to be a key mechanism underlying the therapeutic effects of MPH in ADHD (4).”
Romero-García, R., Hook, R. W., Tiego, J., Bethlehem, R. A. I., Goodyer, I. M., Jones, P. B., Dolan, R. J., Grant, J. E., Bullmore, E. T., Yücel, M., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00848-9 · Cited by 22
Dommett, E. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.001 · Cited by 22
“The dose–response study with ATX (N = 8) (0.1–5.0 mg/kg p.o. t = −30 min; Fig.”
InfluentialStevens, J. R., George, R. A., Fusillo, S. J., Stern, T. A., & Wilens, T. E. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0128 · Cited by 22
“Although an assortment of treatment strategies has been employed, methylphenidate (MPH) is the most commonly prescribed psychotropic for the treatment of ADHD among pediatric patients (Greenhill et al. 2002; Arnsten 2006).”
Segat, H. J., Martini, F., Barcelos, R. C. S., Brüning, C. A., Nogueira, C. W., & Bürger, M. E. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.002 · Cited by 22
Using fNIRS to evaluate ADHD medication effects on neuronal activity: A systematic literature review
Poliakova, E., Conrad, A. L., Schieltz, K. M., & O’Brien, M. J. (2023) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2023.1083036 · Cited by 21
Xu, L., Hu, Y., Huang, L., Liu, Y., Wang, B., Xie, L., & Hu, Z. (2019) · Anaesthesia · doi:10.1111/anae.14496 · Cited by 20
“Adult patients with untreated ADHD have defects in dopaminergic transmission in the substantia nigra, especially in the density of postsynaptic D2 and D3 receptor subtypes, the function of which might be improved by benzedrine, a dopamine receptor agonist [25, 26].”
BackgroundBridging ADHD and Metabolic Disorders: Insights into Shared Mechanisms and Clinical Implications
Marcelli, I., Capece, U., & Caturano, A. (2025) · Diabetology · doi:10.3390/diabetology6050040 · Cited by 21
“Stimulant medications, such as methylphenidate, are known for their short-term appetite-suppressing effects and subsequent weight loss [113,114].”
Why do stimulants not work in typical depression?
Hegerl, U., & Hensch, T. (2017) · Australian and New Zealand journal of psychiatry (Print) · doi:10.1177/0004867416676369 · Cited by 18
“However, research in this field is complex because effects and side effects of stimulants strongly depend on both outcome variable (e.g. effects on mood vs effects only on drive or attention) and applied dose (Arnsten, 2006; Busardo et al., 2016; Wood et al., 2014).”
Background“Because You’re Worth It”: A Discourse Analysis of the Gendered Rhetoric of the ADHD Woman
Winter, H., Moncrieff, J., & Speed, E. (2015) · Qualitative Research in Psychology · doi:10.1080/14780887.2015.1050748 · Cited by 20
“Third, despite popular views (as illustrated in extracts 2 and 3), stimulant medication has not been shown to have specific effects in people diagnosed with ADHD in comparison with people without the diagnosis, and animals (Arnsten 2006).”
Gronier, B., James, A., Liauzun, C., & Zetterström, T. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359100 · Cited by 20
“It is possible that the large stimulation of neuronal activity and Arc expression in the PFC of adult rats, observed in our study with relatively high doses (3–4mg/kg), contributes to induce PFC-dependent cognitive impairment, as well as locomotor agitation (Arnsten, 2006).”
InfluentialLister hooded rats as a novel animal model of attention-deficit/hyperactivity disorder
Jogamoto, T., Utsunomiya, R., Sato, A., Kihara, N., Choudhury, M. E., Miyanishi, K., Kubo, M., Nagai, M., Nomoto, M., Yano, H., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104857 · Cited by 20
Karam, C. S., Williams, B. L., Jones, S. K., & Javitch, J. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03275-4 · Cited by 19
Are Amphetamines Associated with Adverse Cardiovascular Events Among Elderly Individuals?
Latronica, J. R., Clegg, T. J., Tuan, W., & Bone, C. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.06.210228 · Cited by 19
Tang, B., & Dafny, N. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.06.004 · Cited by 19
Nicotinamide reduces dopamine in postnatal hypothalamus and causes dopamine-deficient phenotype
Lee, J., Ahn, K., Jang, B. G., Park, S., Kang, H.-J., Heo, J., Ko, Y.-J., Won, M., Kang, T., Jo, S. A., et al. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.06.005 · Cited by 19
Kharas, N., Whitt, H., Reyes-Vasquez, C., & Dafny, N. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.011 · Cited by 19
“ADHD is commonly diagnosed during adolescence and management with psychostimulants often continues into adulthood (Arnsten, 2006; Homberg et al., 2016; Polanczyk and Rohde, 2007; Wilens, 2008).”
BackgroundMarchese, N. A., Occhieppo, V. B., Basmadjian, O. M., Casarsa, B. S., Baiardi, G., & Bregonzio, C. (2019) · European Journal of Neuroscience · doi:10.1111/ejn.14605 · Cited by 20
“In this brain area, catecholamine neurotransmission is implicated in the coordination and integration of cues, even though they imply less complex behaviors (Arnsten, 2006; Jones, 2002).”
BackgroundChess, A. C., & Green, J. T. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.1.63 · Cited by 19
“In terms of neurochemistry, there are alterations of catecholamine synthesis and reuptake in ADHD (Arnsten, 2006).”
BackgroundCurrent issues and trends in the diagnosis and treatment of adults with ADHD
Cumyn, L., Kolar, D., Keller, A., & Hechtman, L. T. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.10.1375 · Cited by 19
Neural basis for individual differences in the attention-enhancing effects of methylphenidate
Manza, P., Tomasi, D. G., Demiral, Ş. B., Kojori, E. S., Lildharrie, C., Lin, E., Wang, G., & Volkow, N. D. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2423785122 · Cited by 18
“There is a well - known “inverted U” relationship between dopaminergic signaling and cognitive performance, such that moderate levels of signaling optimize performance, whereas either insufficient or excessive signaling impairs performance ( 62 , 63 ).”
Peña, I. D., Lee, J. C., Lee, H. L., Woo, T. S., Lee, H. C., Sohn, A. R., & Cheong, J. H. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.02.090 · Cited by 18
Improvement of attention with amphetamine in low- and high-performing rats
Turner, K. M., & Burne, T. H. J. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4376-9 · Cited by 18
Canseco-Alba, A., Sanabria, B., Hammouda, M., Bernadin, R., Mina, M., Liu, Q., & Onaivi, E. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.803394 · Cited by 19
Cockburn, J., & Holroyd, C. B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.065 · Cited by 18
“…with the empirical data, the Mc model's response rate during the FI period remained consistent across blocks, whereas the response rate during the EXT blocks decreased, demonstrating that the optimization procedure successfully captured the general learning trends observed in the empirical data.”
BackgroundResultAntidepressants and Adolescent Brain Development
Karanges, E. A., & McGregor, I. S. (2011) · Future Neurology · doi:10.2217/fnl.11.51 · Cited by 18
“Stimulants such as atomoxetine and methylphenidate have both dopaminergic and noradrenergic effects [32].”
BackgroundPark, S., Hong, S., Kim, J.-W., Yang, Y.-H., Park, M.-H., Kim, B., Shin, M., Yoo, H., & Cho, S.-C. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12050121 · Cited by 18
Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults
Hamard, J., Rousseau, V., Durrieu, G., Garcia, P., Yrondi, A., Sommet, A., Revet, A., & Montastruc, F. (2024) · BMJ Mental Health · doi:10.1136/bmjment-2023-300876 · Cited by 18
Evaluation of causality between ADHD and Parkinson's disease: Mendelian randomization study
Li, G. H., Ge, G. M., Cheung, C., Ip, P., Coghill, D., & Wong, I. C. K. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.06.001 · Cited by 17
“Early studies have shown that high doses of AMP might damage dopaminergic pathways(Advokat, 2007; Arnsten, 2006).”
ResultAttention-Deficit Hyperactivity Disorder-Like Traits and Distractibility in the Visual Periphery
Panagiotidi, M., Overton, P. G., & Stafford, T. (2016) · Perception · doi:10.1177/0301006616681313 · Cited by 17
“…the major drawback of working with a clinical ADHD population, where the majority of individuals have been treated chronically with psychostimulant medication (the front-line treatment for ADHD; Arnsten, 2006), which is known to affect oculomotor function (e.g., Dursun, Wright, & Reveley, 1999).”
BackgroundInfluentialStuderus, E., Corbisiero, S., Mazzariello, N., Ittig, S., Leanza, L., Egloff, L., Beck, K., Heitz, U., Andreou, C., Stieglitz, R., et al. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2018.02.006 · Cited by 17
“Specifically, since ADHD is most commonly treated with stimulant drugs which exert their pharmacological effects via increasing the levels of dopamine [25], and since increased levels of synaptic dopamine are implicated in the generation of psychotic symptoms [26], treating ARMS patients as ADHD patients could potenti…”
BackgroundWhen brain stimulation backfires: the effects of prefrontal cortex stimulation on impulsivity
Bell, S. B., Turner, B. W., Sawaki, L. A., & DeWall, N. (2020) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsaa049 · Cited by 17
Pardey, M. C., Kumar, N. N., Goodchild, A. K., Clemens, K. J., Homewood, J., & Cornish, J. L. (2012) · Brain Sciences · doi:10.3390/brainsci2030375 · Cited by 17
“The administration of MPH to those with “normal” catecholamine function also alters cognitive function, with low doses enhancing performance [13] and higher doses increasing catecholamine levels in excess of what is optimal, resulting in PFC impairment [23,54].”
BackgroundADHD and the Disruptive Behavior Disorders
Metcalf, E. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_18 · Cited by 16
Imbalance between dopamine and serotonin caused by neonatal habenula lesion
Lee, Y., Kim, Y., Lee, J., Lee, S., & Goto, Y. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113316 · Cited by 16
The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment
Sun, H., Wu, M., Wang, M., Zhang, X., & Zhu, J. Z. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1032607 · Cited by 16
“At the cellular level, Sig-1R is post-synaptic (Hayashi and Su, 2004) and is an excitatory target for the treatment of ADHD (e.g., cocaine) (Matsumoto et al., 2001; Maurice et al., 2002).”
BackgroundInfluentialBoyce, P. J., & Finlay, J. M. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.01.012 · Cited by 16
Ivanov, I., Liu, X., Clerkin, S. M., Schulz, K. P., Fan, J., Friston, K. J., London, E. D., Schwartz, J., & Newcorn, J. H. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.01.017 · Cited by 16
“These effects, suggesting improved efficiency and enhanced taskrelated information processing in relevant neuroanatomical networks (Arnsten, 2006), are related to cognitive impairments associated with attention deficit-hyperactivity disorder (ADHD), depression, substance use disorders, and other…”
BackgroundÜnal, D., Unal, M. F., Alikaşifoğlu, M., & Çetinkaya, A. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.4.427 · Cited by 16
Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
Kuypers, K. P. C., Perna, E. B. D. S. F., Dolder, P. C., Toennes, S. W., Theunissen, E. L., Mason, N. L., Hutten, N. R. P. W., & Ramaekers, J. G. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4931-7 · Cited by 16
“Additionally, stimulants like amphetamine and cocaine have shown to exert enhancing effects on response control in individuals with impulse control problems, like ADHD and drug addiction (Arnsten 2006; Fillmore et al. 2002, 2005).”
BackgroundAssociation Between DRD2 and DRD4 Polymorphisms and Eating Disorders in an Italian Population
Ceccarini, M. R., Fittipaldi, S., Ciccacci, C., Granese, E., Centofanti, F., Ragione, L. D., Bertelli, M., Beccari, T., & Botta, A. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.838177 · Cited by 17
Kubas, H. A., Backenson, E. M., Wilcox, G., Piercy, J. C., & Hale, J. B. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2592 · Cited by 15
Sterley, T.-L., Howells, F. M., & Russell, V. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.019 · Cited by 15
McFadden, L. M., & Matuszewich, L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.016 · Cited by 15
Park, M.-S., Byun, K.-W., Park, Y.-K., Kim, M.-H., Jung, S.-H., & Kim, H. K. (2013) · Journal of Exercise Rehabilitation · doi:10.12965/jer.130017 · Cited by 15
Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
Hammerness, P., Fried, R., Petty, C., Meller, B., & Biederman, J. (2014) · Child Neuropsychology · doi:10.1080/09297049.2013.790359 · Cited by 14
“Such stimulant exposure may provide levels of catecholamine stimulation (i.e., in the setting of optimized stimulant medication) necessary to improve prefrontal regulation of attention and behavior and attendant cognitive outcomes (Arnsten, 2006, 2009).”
BackgroundMethylphenidate as a causal test of translational and basic neural coding hypotheses
Ni, A. M., Bowes, B., Ruff, D. A., & Cohen, M. R. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2120529119 · Cited by 14
Tokuda, T., Ikeda, T., Monden, Y., Mizushima, S. G., Inoue, T., Nagashima, M., Shimamura, K., Akari, A., Kobayashi, M. S., Kuroiwa, C., et al. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000418 · Cited by 14
Blasco-Fontecilla, H. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12165350 · Cited by 14
Surman, C. B. H., Ceranoglu, A. T., Vaudreuil, C., Albright, B. B., Uchida, M., Yule, A. M., Spencer, A. E., Boland, H., Grossman, R. C., Rhodewalt, L., et al. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000990 · Cited by 14
Acute Atomoxetine Selectively Modulates Encoding of Reward Value in Ventral Medial Prefrontal Cortex
Suzuki, C., Ikeda, Y., Tateno, A., Okubo, Y., Fukayama, H., & Suzuki, H. (2019) · Journal of Nippon Medical School · doi:10.1272/jnms.jnms.2019_86-205 · Cited by 14
Redondo, B., Molina, R., Vera, J., Muñoz‐Hoyos, A., Barrett, B. T., & Jiménez, R. (2020) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-020-04645-4 · Cited by 14
“methylphenidate and amphetamines) has a beneficial effect on the symptoms of hyperactivity, impulsivity and inattention [25], which seems to be mediated by increasing activation in dopamine and norepinephrine fronto-striatal circuitry [26, 27].”
BackgroundNicholls, E., Hildenbrand, A. K., Aggarwal, R., McCarthy, L., & Daly, B. P. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.09.2596 · Cited by 14
Genetic Variations of α2-Adrenergic Receptors Illuminate the Diversity of Receptor Functions
Cottingham, C., Chen, H., Chen, Y., Peng, Y., & Wang, Q. (2011) · Current topics in membranes · doi:10.1016/b978-0-12-384921-2.00008-2 · Cited by 15
[Immunological and endocrinological pattern in ADHD etiopathogenesis].
Budziszewska, B., Basta‐Kaim, A., Kubera, M., & Lasoń, W. (2010) · PubMed · Cited by 14
New frontiers in pharmacological treatment of attention-deficit hyperactivity disorder
Noah, A. A., & Sedky, H. E. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04328-z · Cited by 14
“While stimulant medications are generally the first choice for treating ADHD, they may not be appropriate for nearly 30% of patients (Arnsten 2006).”
Fujioka, T., Takiguchi, S., Yatsuga, C., Hiratani, M., Hong, K.-E. M., Shin, M., Cho, S., Kosaka, H., & Tomoda, A. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.1.79 · Cited by 13
Ulset, V. S., Czajkowski, N. O., Staton, S., Smith, S. S., Pattinson, C. L., Allen, A., Thorpe, K. J., & Bekkhus, M. (2021) · Journal of Environmental Psychology · doi:10.1016/j.jenvp.2021.101560 · Cited by 13
KTN1 variants and risk for attention deficit hyperactivity disorder
Luο, X., Guo, X., Tan, Y., Zhang, Y., García-Milian, R., Wang, Z., Shi, J., Yu, T. Y., Ji, J., Wang, X., et al. (2020) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32782 · Cited by 13
“Primary pharmacological regimens for ADHD, including methylphenidate (Ritalin) and amphetamine (Adderal), increase the dopamine levels (Arnsten, 2006).”
BackgroundAppetitive Needs and Addiction
Sussman, S. Y., & Pakdaman, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.004 · Cited by 12
Lewandrowski, K., Blum, K., Sharafshah, A., Thanos, K. Z., Thanos, P. K., Zirath, R., Pinhasov, A., Bowirrat, A., Jafari, N., Zeine, F., et al. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15030103 · Cited by 12
The paradoxical nature of nature
Kapur, N., Pascual‐Leone, Á., Manly, T., & Cole, J. D. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511978098.003 · Cited by 12
Kobayashi, M. S., Ikeda, T., Tokuda, T., Monden, Y., Nagashima, M., Mizushima, S. G., Inoue, T., Shimamura, K., Ujiie, Y., Akari, A., et al. (2020) · Neurophotonics · doi:10.1117/1.nph.7.2.025003 · Cited by 12
“It is believed that MPH increases synaptic transmission by inhibiting reuptake of catecholamines, mainly DA, and acts as a DA agonist in the cerebral cortices.(21) Although it is known that MPH affects both the DA and NA systems,(22,23) effects on the DA system are far greater than those on the NA system because MPH h…”
BackgroundBerro, L. F., Moreira-Junior, E. D. C., & Rowlett, J. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108930 · Cited by 12
Mazzetti, C., Damatac, C. G., Sprooten, E., ter Huurne, N., Buitelaar, J. K., & Jensen, O. B. (2022) · Psychophysiology · doi:10.1111/psyp.14008 · Cited by 12
“…et al., 2012; Jenni et al., 2017; Tomasi et al., 2016), some of which structurally rely on the SLF. Dopaminergic availability is modulated by MPH (Arnsten, 2006; Devilbiss et al., 2006; Faraone, 2018), which blocks the reuptake of the neurotransmitter, hence allegedly increasing the functional…”
BackgroundWigal, S. B., Polzonetti, C. M., Stehli, A., & Gratton, E. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.12.127002 · Cited by 12
Kim, Y., Goto, Y., & Lee, Y. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000343 · Cited by 12
Qualitative Approaches to the Study of Substance and Behavioral Addictions
Simpson, K. A., & Bluthenthal, R. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.013 · Cited by 11
Montoya, A., Escobar, R., García-Polavieja, M. J., Lachno, D. R., Alda, J. A., Artigas-Pallarés, J., Cardo, E., Giral, M. G., Gastaminza, X., & Gilaberte, I. (2010) · Journal of Child Neurology · doi:10.1177/0883073810371981 · Cited by 11
Kim, J.-S., Lee, K. H., Hwang, C.-S., & Kim, J.-W. (2022) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.210074 · Cited by 11
Metadata
- Authors
- Arnsten, A. F. T.
- Affiliations
- Yale University (US)
- Corresponding author
- Arnsten, Amy F T
- ORCID
- Arnsten, Amy F T
- Venue
- Neuropsychopharmacology
- Published
- 2006-07-19
- Volume
- 31
- Issue
- 11
- Pages
- 2376-2383
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W1989057449
- Cited by
- 473
- References
- 110
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 18 · 2023: 14 · 2022: 19 · 2021: 20 · 2020: 59 · 2019: 11 · 2018: 20 · 2017: 13 · 2016: 30 · 2015: 16 · 2014: 23 · 2013: 27 · 2012: 36
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Yale University
- Shire
- National Institutes of Health (5r21mh066393-03)
- National Institute on Aging (R37AG006036, R37 AG06036)
- National Institute of Mental Health (R21-MH066393)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- attention deficit hyperactivity disorder, stimulant medication, methylphenidate, amphetamine, prefrontal cortex, norepinephrine, dopamine, catecholamines, alpha2-adrenoceptors, dopamine D1 receptor, alpha1-adrenoceptors, working memory, executive function, attention, locomotor activity
- MeSH terms
- Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Catecholamines, Dose-Response Relationship, Drug, Humans, Methylphenidate, Prefrontal Cortex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.